| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/IJC.2910450523 |
| P698 | PubMed publication ID | 2335394 |
| P2093 | author name string | C Lechner | |
| R Pirker | |||
| H Ludwig | |||
| M Raschack | |||
| G Keilhauer | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple drug resistance | Q643839 |
| P304 | page(s) | 916-919 | |
| P577 | publication date | 1990-05-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Reversal of multi-drug resistance in human KB cell lines by structural analogs of verapamil | |
| P478 | volume | 45 |
| Q73073722 | Achiral and chiral high-performance liquid chromatography of verapamil and its metabolites in serum samples |
| Q41312990 | Comparison of solutol HS 15, cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agents |
| Q54183829 | Dexverapamil as resistance modifier in acute myeloid leukaemia. |
| Q54183821 | Dexverapamil to overcome epirubicin resistance in advanced breast cancer. |
| Q36115974 | Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas |
| Q39733379 | Hydrocinchonine, cinchonine, and quinidine potentiate paclitaxel-induced cytotoxicity and apoptosis via multidrug resistance reversal in MES-SA/DX5 uterine sarcoma cells |
| Q28543846 | Inhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to Praziquantel |
| Q50751783 | Inhibitory effect of calcium channel blockers on human mesangial cell growth: evidence for actions independent of L-type Ca2+ channels. |
| Q44066766 | MDR1 RNA expression as a prognostic factor in acute myeloid leukemia: an update |
| Q35977393 | MDR1 gene expression in primary colorectal carcinomas |
| Q58136246 | Multidrug Resistance |
| Q34060806 | Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs |
| Q41324683 | Novel dithiane analogues of tiapamil with high activity to overcome multidrug resistance in vitro |
| Q44969910 | Novel sites for phenylalkylamines: characterisation of a sodium-sensitive drug receptor with (−)-[3H]emopamil |
| Q35718765 | P glycoprotein in human immunodeficiency virus type 1 infection and therapy |
| Q27024260 | P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review |
| Q40810038 | P-glycoprotein, glutathione and glutathione S-transferase increase in a colon carcinoma cell line by colchicine |
| Q45871082 | P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells |
| Q40535280 | Pharmacologic circumvention of multidrug resistance |
| Q36292342 | Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer |
| Q36175434 | Reversal of anticancer multidrug resistance by the ardeemins |
| Q58032690 | Reversal of multidrug resistance by B859-35, a metabolite of B859-35, niguldipine, verapamil and nitrendipine |
| Q35294152 | Structure and function of efflux pumps that confer resistance to drugs |
| Q73705879 | Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity |
| Q43989163 | Verapamil sensitisation to alkaloids on colchicine-selected human colon adenocarcinoma cells |
Search more.